Real-World Dosing Patterns of Atomoxetine in Adults with Attention-Deficit/Hyperactivity Disorder.

Authors:
Kabul S; Alatorre C; Montejano LB; Farr AM; Clemow DB.

Journal:
CNS Neurosci Ther

Publication Year: 2015

DOI:
10.1111/cns.12442

PMCID:
PMC5049605

PMID:
26331467

View on PubMed View on PMC View Publisher
Journal Information

Full Title: CNS Neurosci Ther

Abbreviation: CNS Neurosci Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Aberrant microstructural integrity of white matter in mild and severe orthostatic hypotension: A NO…
Cheng Y; Lin L; Jiang S and 6 more (2024) - Transparency Score: 3/6
Absence in CX3CR1 receptor signaling promotes post-ischemic stroke cognitive function recovery thro…
Ge Y; Yang J; Chen J and 5 more (2024) - Transparency Score: 3/6
Acetyl-11-keto-beta-boswellic acid modulates macrophage polarization and Schwann cell migration to …
Wang Y; Xiong Z; Qiao Y and 6 more (2024) - Transparency Score: 3/6
Activation of testosterone-androgen receptor mediates cerebrovascular protection by photobiomodulat…
Feng Y; Huang Z; Ma X and 6 more (2024) - Transparency Score: 3/6
Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization.
He Q; Wang Y; Fang C and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures This study was funded by Eli Lilly and Company. Drs. Kabul, Alatorre, and Clemow are employees of Eli Lilly and Company. Truven Health Analytics received funding from Eli Lilly and Company to conduct this analysis. Ms. Montejano and Ms. Farr are employees of Truven Health Analytics. Conflict of Interest The authors declare no conflict of interest."

Evidence found in paper:

"This study was funded by Eli Lilly and Company. Drs. Kabul, Alatorre, and Clemow are employees of Eli Lilly and Company. Truven Health Analytics received funding from Eli Lilly and Company to conduct this analysis. Ms. Montejano and Ms. Farr are employees of Truven Health Analytics."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025